Gerresheimer AG (GRRMF)
OTCMKTS · Delayed Price · Currency is USD
51.41
0.00 (0.00%)
Sep 16, 2025, 8:00 PM EDT
Gerresheimer AG Market Cap
Gerresheimer AG has a market cap or net worth of $1.79 billion as of September 18, 2025. Its market cap has decreased by -54.71% in one year.
Market Cap
1.79B
Enterprise Value
4.35B
Revenue
2.48B
Ranking
n/a
PE Ratio
24.90
Stock Price
$51.41
Market Cap Chart
Since June 11, 2007, Gerresheimer AG's market cap has increased from 1.61B to 1.79B, an increase of 11.08%. That is a compound annual growth rate of 0.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 1.79B | -29.76% |
| Dec 30, 2024 | 2.54B | -29.36% |
| Dec 29, 2023 | 3.60B | 70.93% |
| Dec 30, 2022 | 2.11B | -30.02% |
| Dec 30, 2021 | 3.01B | -11.06% |
| Dec 30, 2020 | 3.39B | 39.32% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 694.19M |
| Tian'an Technology Group | 609.94M |
| Glass House Brands | 567.62M |
| Northwest Biotherapeutics | 378.51M |
| CytoDyn | 368.77M |
| American Oncology Network | 345.48M |